Zearalenone-induced aberration in the composition of the gut microbiome and function impacts the ovary reserve

Chemosphere. 2020 Apr:244:125493. doi: 10.1016/j.chemosphere.2019.125493. Epub 2019 Nov 29.

Abstract

Zearalenone (ZEA), as a contaminant commonly found in our daily diet, has been widely studied for its toxicity. However, the exact mechanism underlying ZEA induced reproduction disorders remains unclear. Our study aimed to elucidate the underlying relationship between aberrations in the gut microbiota and the degeneration of the ovarian reserve following exposure to ZEA. Four-week-old mice were treated with different doses (0, 20, 40 μg/kg bw/day) of ZEA for 2 weeks and it was found that the primordial follicles were dramatically decreased when compared to untreated controls. Moreover, we applied metagenomic shotgun sequencing to investigate the effects of ZEA exposure on the population composition and function of gut microbiota. The results showed that the abundance of three susceptible bacterial strains, parabacteroides, bacteroides and lachnospiraceae were increased in a dose-dependent manner after ZEA exposure, whereas the bacterial glycerophospholipid metabolism pathway was greatly suppressed. Of note, utilizing LC/MS we found lysophosphatidylcholines (LPCs), important metabolites in the process of glycerophospholipid metabolism, were markedly decreased in the plasma of the ZEA treated mice. In conclusion, our findings here provide evidences that the dysfunction in gut microbiome after ZEA exposure may affect the ovarian reserve.

Keywords: Gut microbiome; Lysophosphatidylcholines; Reproductive disorder; Zearalenone.

MeSH terms

  • Animals
  • Bacteria / drug effects
  • Female
  • Gastrointestinal Microbiome / drug effects*
  • Glycerophospholipids / metabolism
  • Lysophospholipids / blood
  • Mice
  • Ovarian Follicle / drug effects
  • Ovarian Reserve / drug effects*
  • Ovary / drug effects
  • Zearalenone / toxicity*

Substances

  • Glycerophospholipids
  • Lysophospholipids
  • Zearalenone
  • lysophosphatidic acid